A mechanistic pan-cancer pathway model informed by multi-omics data interprets stochastic cell fate responses to drugs and mitogens
Open accessPublished version of a preprint
The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Abstract
Most cancer cells harbor multiple drivers whose epistasis and interactions with expression context clouds drug and drug combination sensitivity prediction. We constructed a mechanistic computational model that is context-tailored by omics data to capture regulation of stochastic proliferation and death by pan-cancer driver pathways. Simulations and experiments explore how the coordinated dynamics of RAF/MEK/ERK and PI-3K/AKT kinase activities in response to synergistic mitogen or drug combinations control cell fate in a specific cellular context. In this MCF10A cell context, simulations suggest that synergistic ERK and AKT inhibitor-induced death is likely mediated by BIM rather than BAD, which is supported by prior experimental studies. AKT dynamics explain S-phase entry synergy between EGF and insulin, but simulations suggest that stochastic ERK, and not AKT, dynamics seem to drive cell-to-cell proliferation variability, which in simulations is predictable from pre-stimulus fluctuations in C-Raf/B-Raf levels. Simulations suggest MEK alteration negligibly influences transformation, consistent with clinical data. Tailoring the model to an alternate cell expression and mutation context, a glioma cell line, allows prediction of increased sensitivity of cell death to AKT inhibition. Our model mechanistically interprets context-specific landscapes between driver pathways and cell fates, providing a framework for designing more rational cancer combination therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Only the model by Bouhaddou et al. (2018) covers more unique protein or gene species (Figure 1D).”
From Efficient Parameter Estimation Enables the Prediction of Drug Response Using a Mechanistic Pan-Cancer Pathway Model (2018) · cites this paper as Bouhaddou et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The FAIR Guiding Principles for scientific data management and stewardship
Wilkinson, M. D., Dumontier, M., Aalbersberg, I. J., Appleton, G., Axton, M., Baak, A., Blomberg, N., Boiten, J.-W., da Silva Santos, L. B., Bourne, P. E., et al. (2016) · Scientific Data · doi:10.1038/sdata.2016.18 · Cited by 18,423
Self-citationSørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566
Alberts, B., Johnson, A., Lewis, J., Morgan, D., Raff, M., Roberts, K., & Walter, P. (2017) · W.W. Norton eBooks · doi:10.1201/9781315735368 · Cited by 6,365
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243
CellProfiler: image analysis software for identifying and quantifying cell phenotypes
Carpenter, A. E., Jones, T. R., Lamprecht, M. R., Clarke, C., Kang, I. H., Friman, O., Guertin, D. A., Chang, J. H., Lindquist, R. A., Moffat, J., et al. (2006) · Genome Biology · doi:10.1186/gb-2006-7-10-r100 · Cited by 5,157
The Large-Scale Organization of Metabolic Networks
Jeong, H., Tombor, B., Albert, R., Oltvai, Z. N., & Barabási, A.-L. (2000) · Nature · doi:10.1038/35036627 · Cited by 4,972
In-gel digestion for mass spectrometric characterization of proteins and proteomes
Shevchenko, A., Tomas, H., Havli, J., Olsen, J. V., & Mann, M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.468 · Cited by 4,942
Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., & Walter, P. (2007) · W.W. Norton eBooks · doi:10.1201/9780203833445 · Cited by 4,589
Research works printed but not linked: 3
- T Nakakuki, 2010, Ligand-specific c-fos expression emerges from the spatiotemporal control of ErbB network dynamics, Cell. Elsevier Ltd, 141, 884
- MR Birtwistle, 2007, Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses, Mol Syst Biol, 3, 144, 10.1038/msb4100188 · DOI · Paper page
- B Schwanhausser, 2011, Global quantification of mammalian gene expression control, Nature, 473, 337, 10.1038/nature10098 · DOI · Paper page
Cited by
Fröhlich, F., Kessler, T., Weindl, D., Shadrin, A., Schmiester, L., Hache, H., Muradyan, A., Schütte, M., Lim, J.-H., Heinig, M., et al. (2018) · Cell Systems · doi:10.1016/j.cels.2018.10.013 · Cited by 143
“Only the model by Bouhaddou et al. (2018) covers more unique protein or gene species (Figure 1D).”
BackgroundMethodWu, C., Lorenzo, G., Hormuth, D. A., Lima, E. A. B. F., Slavkova, K. P., DiCarlo, J. C., Virostko, J. M., Phillips, C. M., Patt, D. A., Chung, C. D., et al. (2022) · Biophysics Reviews · doi:10.1063/5.0086789 · Cited by 171
Simulation-assisted machine learning
Deist, T. M., Patti, A., Wang, Z., Krane, D., Sorenson, T., & Craft, D. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz199 · Cited by 77
Zhao, C., Mirando, A. C., Sové, R. J., Medeiros, T. X., Annex, B. H., & Popel, A. S. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007468 · Cited by 66
A comprehensive review of computational cell cycle models in guiding cancer treatment strategies
Ma, C., & Gürkan-Çavusoglu, E. (2024) · npj Systems Biology and Applications · doi:10.1038/s41540-024-00397-7 · Cited by 76
“Thismulti-omicstailoredmodeloffersinsights intothecontextualcontrolofcellproliferationanddeathinresponseto drugsandmitogens 134 .”
Systems biology of angiogenesis signaling: Computational models and omics
Zhang, Y., Wang, H., Oliveira, R. H. D. M., Zhao, C., & Popel, A. S. (2021) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1550 · Cited by 60
Alkan, O., Schoeberl, B., Shah, M., Koshkaryev, A., Heinemann, T., Drummond, D. C., Yaffe, M. B., & Raue, A. (2018) · Science Signaling · doi:10.1126/scisignal.aat0229 · Cited by 51
Zhao, C., Medeiros, T. X., Sové, R. J., Annex, B. H., & Popel, A. S. (2021) · iScience · doi:10.1016/j.isci.2021.102112 · Cited by 47
“For the IL-10 pathway, a previous model by Braun et al. (2013) was taken as a basis from which we further added corresponding mechanisms to describe the activation of PI3K/AKT (phosphoinositide 3-kinase/protein kinase B) and ERK (extracellular signal-regulated kinase) by IL-10 and also the…”
MethodEfficient parameterization of large-scale dynamic models based on relative measurements
Schmiester, L., Schälte, Y., Fröhlich, F., Hasenauer, J., & Weindl, D. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz581 · Cited by 42
“With the availability of scalable computational methods and increasing computing power, larger and larger models have been developed to capture the intricacies of biological regulatory networks more accurately (Bouhaddou et al., 2018; Fröhlich et al., 2018). In Fröhlich et al. (2018), we demonstrated how such a large-…”
MethodKazerouni, A. S., Gadde, M., Gardner, A. L., Hormuth, D. A., Jarrett, A. M., Johnson, K. E., Lima, E. A. B. F., Lorenzo, G., Phillips, C. M., Brock, A., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101807 · Cited by 39
“…high-dimensional multi-omics data, including patient-derived RNA-seq data, to construct an ODEmodel that integrated stochastic fluctuations in expression of commonly mutated cancer pathways and showed how these fluctuations influence tumor cell proliferation and death (Bouhaddou et al., 2018).”
BackgroundBouhaddou, M., Yu, L. J., Lunardi, S., Stamatelos, S. K., Mack, F. A., Gallo, J. M., Birtwistle, M. R., & Walz, A. (2019) · Clinical and Translational Science · doi:10.1111/cts.12727 · Cited by 33
“Biomarker levels In vitro Yes (3) Yes (3) Both”
BackgroundSelf-citationAghakhani, S., Zerrouk, N., & Niarakis, A. (2020) · Cancers · doi:10.3390/cancers13010035 · Cited by 36
“A mechanistic pan-cancer pathway model was developed to study stochastic cell fate responses to several drugs and mitogens [129].”
BackgroundMini-batch optimization enables training of ODE models on large-scale datasets
Stapor, P. L., Schmiester, L., Wierling, C., Merkt, S., Pathirana, D., Lange, B. M. H., Weindl, D., & Hasenauer, J. (2022) · Nature Communications · doi:10.1038/s41467-021-27374-6 · Cited by 36
Zhang, S., Gong, C., Ruiz-Martínez, Á., Wang, H., Davis-Marcisak, E. F., Deshpande, A. M., Popel, A. S., & Fertig, E. J. (2021) · ImmunoInformatics · doi:10.1016/j.immuno.2021.100002 · Cited by 32
“The conventional computational models include, but not limited to, mechanistic models [69-71], statistical models [72,73], and data-driven models [74].”
BackgroundPatient-Specific Multi-Omics Models and the Application in Personalized Combination Therapy
John, A. J., Qin, B., Kalari, K. R., Wang, L., & Yu, J. (2020) · Future Oncology · doi:10.2217/fon-2020-0119 · Cited by 31
Erdem, C., Mutsuddy, A., Bensman, E. M., Dodd, W. B., Saint-Antoine, M., Bouhaddou, M., Blake, R., Gross, S. M., Heiser, L. M., Feltus, F. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31138-1 · Cited by 32
Self-citationA New Era of Neuro-Oncology Research Pioneered by Multi-Omics Analysis and Machine Learning
Takahashi, S., Takahashi, M., Tanaka, S., Takayanagi, S., Takami, H., Yamazawa, E., Nambu, S., Miyake, M., Satomi, K., Ichimura, K., et al. (2021) · Biomolecules · doi:10.3390/biom11040565 · Cited by 27
“21 2018 A mechanistic pan-cancer pathway model informed by multi-omics data interprets stochastic cell fate responses to drugs and mitogens [62] Cell line Gene expression, copy number change profiles, protein expression GBM Miscellaneous LASSO* and support vector machine*”
BackgroundMulti-scale models of whole cells: progress and challenges
Georgouli, K., Yeom, J.-S., Blake, R. C., & Navid, A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1260507 · Cited by 22
Validating Antibodies for Quantitative Western Blot Measurements with Microwestern Array
Koch, R. J., Barrette, A. M., Stern, A. D., Hu, B., Bouhaddou, M., Azeloglu, E. U., Iyengar, R., & Birtwistle, M. R. (2018) · Scientific Reports · doi:10.1038/s41598-018-29436-0 · Cited by 19
Self-citationOBIF: an omics-based interaction framework to reveal molecular drivers of synergy
García, J. P., Kulkarni, V. V., Reese, T. C., Wali, S., Wase, S. J., Zhang, J., Singh, R., Caetano, M. S., Kadara, H. N., Moghaddam, S. J., et al. (2022) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqac028 · Cited by 19
Relating individual cell division events to single-cell ERK and Akt activity time courses
Stern, A. D., Smith, G. R., SANTOS, L. V. D. S., Sarmah, D., Zhang, X., Lu, X., Iuricich, F., Pandey, G. S., Iyengar, R., & Birtwistle, M. R. (2022) · Scientific Reports · doi:10.1038/s41598-022-23071-6 · Cited by 20
Self-citationWei, P., Gu, H., Liu, J. H., & Wang, Z. (2018) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2018.10.015 · Cited by 16
“pathway model based on chemical kinetics approach [40] A systematic model assembled with six created“submodels” (the RTK-Ras-Raf pathway, the PI3K-AKT-mTOR pathway, cell cycle pathways, and p53-DNA repair pathways, apoptosis pathways, and gene expression and degradation processes.”
MethodCombination treatment optimization using a pan-cancer pathway model
Schmucker, R., Farina, G., Faeder, J. R., Fröhlich, F., Saglam, A. S., & Sandholm, T. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009689 · Cited by 21
Barrette, A. M., Bouhaddou, M., & Birtwistle, M. R. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00197 · Cited by 19
Self-citationEpigenetic instability may alter cell state transitions and anticancer drug resistance
Saini, A., & Gallo, J. M. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009307 · Cited by 12
“Both the relevant parameters regarding the MGMT transcription and translation, and the MGMT-O6mG complex degradation rate constant were taken from the literature [49,50].”
MethodBuilding patient‐specific models for receptor tyrosine kinase signaling networks
Ebata, K., Yamashiro, S., Iida, K., & Okada, M. (2021) · FEBS Journal · doi:10.1111/febs.15831 · Cited by 12
“Parameter estimation is an important issue in ODE modeling, but biological modeling in general is being analyzed on a larger scale [123].”
BackgroundChude-Okonkwo, U. A. K. (2021) · International Conference on Signal Processing and Communication Systems · doi:10.1109/icspcs53099.2021.9660222 · Cited by 10
Predicting anti-cancer drug combination responses with a temporal cell state network model
Sarmah, D., Meredith, W. O., Weber, I. K., Price, M. R., & Birtwistle, M. R. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011082 · Cited by 12
Self-citationAnalysis of copy number loss of the ErbB4 receptor tyrosine kinase in glioblastoma
Jones, D. C., Scanteianu, A., DiStefano, M. S., Bouhaddou, M., & Birtwistle, M. R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190664 · Cited by 11
Self-citationErdem, C., & Birtwistle, M. R. (2023) · Frontiers in Systems Biology · doi:10.3389/fsysb.2023.1099413 · Cited by 9
“The species initial conditions are updated using LINCS (Gross et al., 2022), MCF10A (Bouhaddou et al., 2018), or other literature datasets (Schwanhäusser et al., 2011).”
BackgroundMethodInfluentialSelf-citationSimon, M., Konrath, F., & Wolf, J. (2024) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2024.100533 · Cited by 8
“…for the generation of personalised disease models are as follows: i) the requirement of huge amount of data sets for the training of the large-scale models [31,59] and ii) the mapping of the output of signalling models to phenotypic readouts to capture disease-relevant cell fate decisions.”
Quantitative Systems Pharmacology models as a key to translational medicine
Schoeberl, B. (2019) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2019.10.019 · Cited by 7
Ortiz-González, A., González-Pérez, P. P., Cárdenas-García, M., & Hernández-Linares, M. G. (2022) · Cancer Informatics · doi:10.1177/11769351221087028 · Cited by 7
Efficient computation of steady states in large-scale ODE models of biochemical reaction networks
Lines, G. T., Paszkowski, Ł., Schmiester, L., Weindl, D., Stapor, P. L., & Hasenauer, J. (2019) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2019.12.232 · Cited by 7
Computer Simulation for Effective Pharmaceutical Kinetics and Dynamics: A Review
Tiwari, G., Shukla, A., Singh, A. M., & Tıwarı, R. (2023) · Current Computer - Aided Drug Design · doi:10.2174/1573409919666230228104901 · Cited by 18
Saini, A., Ballesta, A., & Gallo, J. M. (2023) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12916 · Cited by 5
Feng, J., Zhang, X., & Tian, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810204 · Cited by 5
“Additionally, a multi-omics integration model combined RNA-sequencing data [146] and proteomic data [97] to predict the coordinated dynamics of the ERK and AKT pathways in response to synergistic mitogen or drug combinations [147].”
BackgroundLogic-based machine learning predicts how escitalopram attenuates cardiomyocyte hypertrophy
Eggertsen, T. G., Travers, J. G., Hardy, E. J., Wolf, M. J., McKinsey, T. A., & Saucerman, J. J. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2420499122 · Cited by 8
“For example, LogiRx may be amenable for integrating drug screens and mechanistic network models in areas such as myofibroblast transformation for fibrosis ( 62 , 63 ) and proliferation for breast cancer ( 64 , 65 ).”
Inhibition of RPS6K reveals context-dependent Akt activity in luminal breast cancer cells
Erdem, C., Lee, A. V., Taylor, D. L., & Lezon, T. R. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009125 · Cited by 3
Marucci, L., Barberis, M., Karr, J. R., Ray, O., Race, P. R., Andrade, M. D. S., Grierson, C., Hoffmann, S. A., Landon, S., Rech, E. L., et al. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00942 · Cited by 51
Mutsuddy, A., Erdem, C., Huggins, J. R., Salim, M., Cook, D., Hobbs, N., Feltus, F. A., & Birtwistle, M. R. (2023) · Bioinformatics Advances · doi:10.1093/bioadv/vbad039 · Cited by 3
Self-citationShin, S., & Nguyen, L. K. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3008-2_17 · Cited by 3
Distributed learning and prediction modelling in radiation oncology
Deist (2019) · Research Publications (Maastricht University) · doi:10.26481/dis.20190405td · Cited by 3
Mechanistic modeling of cell viability assays with in silico lineage tracing
Mutsuddy, A., Huggins, J. R., Amrit, A. K., Harley-Gasaway, A. M., Erdem, C., Jones, E. T., Laurine, O. G., Calhoun, J. C., & Birtwistle, M. R. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013156 · Cited by 1
“In our previous work, stochastic single cell simulations initiated from a representation of a serum-starved MCF10A cell minimally entered S-phase without EGF [21].”
InfluentialSelf-citationSystems-level consequences of low RAF abundance for EGFR-ERK signaling
Lee, S. H., Myers, P. J., Mendrzycki, M. C., Brown, K., Loew, L. M., Sorkin, A. D., & Lazzara, M. J. (2026) · Biophysical Journal · doi:10.1016/j.bpj.2025.12.033 · Cited by 1
“For example, a classification model predicted that fluctuations in RAF1 and BRAF expression engendered cell-to-cell variation in ERK activity and proliferation among MCF10A cells (93).”
Stochastic modeling of gene expression: application of ensembles of trajectories
Torkaman, P., & Jafarpour, F. H. (2019) · Physical Biology · doi:10.1088/1478-3975/ab3ea5 · Cited by 1
“Cumulative sum of proteins have also been considered in modeling approaches dealing with cancer therapy [6]; therefore, fluctuations of such qualities could be interesting from biological point of view.”
BackgroundPredicting Individual Cell Division Events from Single-Cell ERK and Akt DynamicsPreprint
Stern, A. D., Smith, G. R., SANTOS, L. V. D. S., Sarmah, D., Zhang, X., Lu, X., Iuricich, F., Pandey, G. S., Iyengar, R., & Birtwistle, M. R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.14.460349 · Cited by 1
Self-citationModelling heterogeneous intracellular networks at the cellular scale
Babtie, A. C. (2019) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2019.10.014
Staff, T. P. C. B. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006189
Shin, S., & Nguyen, L. K. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.07.536087
“To address these issues, mechanistic and dynamic mathematical models, such as Boolean network models (9, 10), dynamic Bayesian networks (11), fuzzy-logic models (12), and ordinary differential equation (ODE) network models (5, 13-16) have been developed for a variety of signaling networks.”
BackgroundWesterhuis, J. A., Heintz‐Buschart, A., Hoefsloot, H. C. J., van der Kloet, F. M., van der Ploeg, G. R., & White, F. T. G. (2025) · Journal of Chemometrics · doi:10.1002/cem.70001
Ma, C., & Gürkan-Çavusoglu, E. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013790
Modeling cell response heterogeneity to pro-apoptotic ligands
Gomes-Pereira, L. C. (2019) · theses.fr (ABES) · doi:10.70675/3c84ed93zf7aaz4ec4zabefz8e73d61a04e1
Toward resolving gravitational effects on microbial growth with computer simulations
Latham, A. P., Skountzos, E. N., Lantin, S., Quarton, T., Ravichandran, A., Lee, J. A., & Lawson, J. W. (2026) · Life Sciences in Space Research · doi:10.64898/2026.05.15.725518
“While kinetic models(12), genome-scale metabolic models(13; 14; 15), integrative models(16; 17), and models based in artificial intelligence(18; 19; 20; 21; 22) have been used to describe the behavior of individual cells, agent based modeling approaches are better equipped to explore how gravity…”
Systems biology during 20 years of PLoS Computational Biology
Alber, M., Birtwistle, M. R., Finley, S. D., & Mendes, P. (2026) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1014465
““bottom-up” descriptions to larger models incorporating more biology and data became possible with improvements to deterministic solvers [27] and hybrid approximations [28], and to agent-based modeling software that enables examining such phenomena in spatial context [29].”
Self-citationStańczak, M., & Niazi, S. K. (2026) · Cells · doi:10.3390/cells15181711
“A smaller operator is preferable when its variables are observable and its falsification boundary is defined [14,66,67].”
Efficient computational frameworks for whole-cell models
Huggins, J. R., & Birtwistle, M. R. (2026) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2026.100610
Self-citation
Metadata
- Authors
- Bouhaddou, M., Barrette, A. M., Stern, A. D., Koch, R. J., DiStefano, M. S., Riesel, E. A., Santos, L. C., Tan, A. L., Mertz, A. E., & Birtwistle, M. R.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Clemson University (US)
- Corresponding author
- Bouhaddou, Mehdi
- Barrette, Anne Marie
- Stern, Alan D.
- Koch, Rick J.
- DiStefano, Matthew S.
- Riesel, Eric A.
- Tan, Annie L.
- Mertz, Alex E.
- Birtwistle, Marc R.
- ORCID
- Venue
- PLOS Computational Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-03-26
- Volume
- 14
- Issue
- 3
- Pages
- e1005985
- ISSN
- 1553-734X (ISSN-L)
- 1553-7358
- PMC
- PMC5886578
- OpenAlex
- W2793626409
- Cited by
- 58
- References
- 149
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 3 · 2023: 8 · 2022: 6 · 2021: 10 · 2020: 5 · 2019: 10 · 2018: 6
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Update notices
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Computational Biology (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institute of General Medical Sciences (P50GM071558, R01GM104184, T32GM062754)
- National Human Genome Research Institute (U54HG008098)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene Regulatory Network Analysis
- Keywords
- MAPK/ERK pathway, PI3K/Akt signaling, building information modeling, Bad, epidermal growth factor, insulin, S phase entry, AKT inhibition, glioma, combination cancer therapy, multi-omics integration
- MeSH terms
- Algorithms, Antineoplastic Agents, Humans, Mitogens, Neoplasms, Stochastic Processes, Signal Transduction, Computational Biology, Gene Expression Profiling, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.